Cell growth inhibition by a novel vitamin K is associated with induction of protein tyrosine phosphorylation

Runzhou Ni, Yuji Nishikawa, Brian I. Carr

Research output: Contribution to journalArticlepeer-review


We have shown that a synthetic vitamin K analog, 2-(2-mercaptoethanol)- 3-methyl-1,4-naphthoquinone or compound 5 (Cpd 5), potently inhibits cell growth and suggested that the analog exerts its effects mainly via sulfhydryl arylation rather than redox cycling. Since protein-tyrosine phosphatases (PTPases), which have pivotal roles in many cellular functions, have a critical cysteine in their active site, we have proposed PTPases as likely targets for Cpd 5. To test this hypothesis, we examined the effects of Cpd 5 on protein tyrosine phosphorylation of cellular proteins and on the activity of PTPases. We found that Cpd 5 rapidly induced protein tyrosine phosphorylation in a human hepatocellular carcinoma cell line (Hep3B) at growth inhibitory doses, and the effect was blocked by thiols but not by non- thiol antioxidants or tyrosine kinase inhibitors. Cpd 5 inhibited PTPase activity, which was also significantly antagonized by reduced glutathione. Furthermore, the well studied PTPase inhibitor orthovanadate also induced protein tyrosine phosphorylation and growth inhibition in Hep3B cells. These results suggest that inhibition of cellular PTPases by sulfhydryl arylation and subsequent perturbation of protein tyrosine phosphorylation may be involved in the mechanisms of Cpd 5-induced cell growth inhibition.

Original languageEnglish
Pages (from-to)9906-9911
Number of pages6
JournalJournal of Biological Chemistry
Issue number16
Publication statusPublished - Apr 17 1998

ASJC Scopus subject areas

  • Biochemistry


Dive into the research topics of 'Cell growth inhibition by a novel vitamin K is associated with induction of protein tyrosine phosphorylation'. Together they form a unique fingerprint.

Cite this